JP2025513767A5 - - Google Patents
Info
- Publication number
- JP2025513767A5 JP2025513767A5 JP2024558208A JP2024558208A JP2025513767A5 JP 2025513767 A5 JP2025513767 A5 JP 2025513767A5 JP 2024558208 A JP2024558208 A JP 2024558208A JP 2024558208 A JP2024558208 A JP 2024558208A JP 2025513767 A5 JP2025513767 A5 JP 2025513767A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- antigen
- antibody
- binding fragment
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210345737.1 | 2022-04-02 | ||
| CN202210345737 | 2022-04-02 | ||
| PCT/CN2023/085417 WO2023186078A1 (zh) | 2022-04-02 | 2023-03-31 | 针对c-Met的抗体及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513767A JP2025513767A (ja) | 2025-04-30 |
| JP2025513767A5 true JP2025513767A5 (https=) | 2025-06-27 |
Family
ID=88199461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024558208A Pending JP2025513767A (ja) | 2022-04-02 | 2023-03-31 | ｃ－Ｍｅｔに対する抗体及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4506361A1 (https=) |
| JP (1) | JP2025513767A (https=) |
| KR (1) | KR20240170835A (https=) |
| CN (1) | CN119013297A (https=) |
| AU (1) | AU2023243881A1 (https=) |
| MX (1) | MX2024012147A (https=) |
| WO (1) | WO2023186078A1 (https=) |
| ZA (1) | ZA202407983B (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| HN2004000285A (es) * | 2003-08-04 | 2006-04-27 | Pfizer Prod Inc | ANTICUERPOS DIRIGIDOS A c-MET |
| US8101727B2 (en) * | 2006-03-30 | 2012-01-24 | Novartis Ag | Compositions and methods of use for antibodies of c-Met |
| JP7325339B2 (ja) * | 2017-05-30 | 2023-08-14 | チョン クン ダン ファーマシューティカル コーポレーション | 新規な抗ｃ－Ｍｅｔ抗体およびその用途 |
-
2023
- 2023-03-31 WO PCT/CN2023/085417 patent/WO2023186078A1/zh not_active Ceased
- 2023-03-31 JP JP2024558208A patent/JP2025513767A/ja active Pending
- 2023-03-31 AU AU2023243881A patent/AU2023243881A1/en active Pending
- 2023-03-31 CN CN202380031407.8A patent/CN119013297A/zh active Pending
- 2023-03-31 EP EP23778442.6A patent/EP4506361A1/en active Pending
- 2023-03-31 KR KR1020247036670A patent/KR20240170835A/ko active Pending
-
2024
- 2024-09-30 MX MX2024012147A patent/MX2024012147A/es unknown
- 2024-10-22 ZA ZA2024/07983A patent/ZA202407983B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022535553A5 (https=) | ||
| CN115551889A (zh) | 抗cd73抗体及其用途 | |
| KR102190548B1 (ko) | 항-her2 항체-약물 접합체 | |
| JP2022515318A5 (https=) | ||
| JP2025514636A5 (https=) | ||
| JP2022526764A5 (https=) | ||
| TW202537975A (zh) | 抗體－藥物結合物之製造方法 | |
| JP2020529863A (ja) | 抗ｒｏｒ１抗体とその作製及び使用方法 | |
| JP2021511811A5 (https=) | ||
| KR20190066026A (ko) | 항 her2 항체-약물 콘주게이트 투여에 의한 내성암의 치료 | |
| JP2022533418A5 (https=) | ||
| RU2011115117A (ru) | Нацеленные средства связывания, направленные на dll4, и их применение | |
| JP7094893B2 (ja) | エンドシアリン結合抗体 | |
| JP2010535713A5 (https=) | ||
| JP2020527332A5 (https=) | ||
| US10358498B2 (en) | Human anti-FGFR4 antibody | |
| JP2013534515A5 (ja) | 受容体型チロシンキナーゼｃ−Ｍｅｔに対する抗体 | |
| US20150175712A1 (en) | Antagonist to an enzyme and/or a metabolite of the kynurenine pathway | |
| JP2025512119A5 (https=) | ||
| CN115210261A (zh) | 抗半乳糖凝集素-9抗体及其用途 | |
| JP2024532836A5 (https=) | ||
| JP2025513767A5 (https=) | ||
| Wang et al. | Construction of a novel TROP2/CD3 bispecific antibody with potent antitumor activity and reduced induction of Th1 cytokines | |
| JP2026511090A (ja) | 癌治療における患者選択のためのＣＥＡＣＡＭ５ ｍＲＮＡアッセイ | |
| CN121517560A (zh) | 一种双特异性抗体及其应用 |